Aurinia Pharmaceuticals Inc (NAS:AUPH)
$ 5.3 0.08 (1.54%) Market Cap: 758.00 Mil Enterprise Value: 513.76 Mil PE Ratio: 0 PB Ratio: 2.12 GF Score: 72/100

Q3 2019 Aurinia Pharmaceuticals Inc Earnings Call Transcript

Nov 14, 2019 / 09:30PM GMT
Release Date Price: $5.14 (-3.93%)
Operator

Greetings and welcome to the Aurinia Pharmaceuticals Third Quarter 2019 Conference Call.

(Operator Instructions) As a reminder, this conference is being recorded.

It's now my pleasure to introduce your host, Glenn Schulman. Please go ahead, Glenn.

Glenn Schulman
Aurinia Pharmaceuticals Inc. - SVP of Corporate Communications & IR

Thank you, Kevin. And good afternoon, everyone. Welcome to Aurinia's Third Quarter 2019 Financial Results Conference Call.

Joining me on the call today from the Aurinia team are Mr. Peter Greenleaf, President and CEO; Dennis Bourgeault, our CFO; Dr. Neil Solomons, Chief Medical Officer; and Mr. Michael Martin, our Chief Operating Officer.

This afternoon, we issued our press release detailing the third quarter 2019 financial results. The press release and the associated financial statement package is available on our website at www.auriniapharma.com, along with the 6-K that was filed with the SEC as well. I'd also like to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot